Loading...
Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease
Despite widespread clinical use in the treatment of type 2 diabetes, the impact of sulfonylurea therapy on cardiovascular outcomes remains uncertain. Studies of naturally occurring genetic variation can be used to anticipate the expected clinical consequences of a pharmacological therapy. A common m...
Na minha lista:
| Udgivet i: | Diabetes |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Diabetes Association
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5521864/ https://ncbi.nlm.nih.gov/pubmed/28411266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db17-0149 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|